Anderson Dematei

Anderson Dematei

Auto-generated profile, based on publicly available information

Anderson Dematei

Núcleo de Pesquisa em Morfologia e Imunologia Aplicada (NuPMIA), Faculdade de Medicina, Universidade de Brasília, Brasília, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2018 in Future Microbiology
Verified
Journal Article
Open access
Lucinda J. BessaLucinda J. Bessa
Lucinda J. Bessa
PEPeter Eaton
Peter Eaton
ADAnderson Dematei
Anderson Dematei
Alexandra PlácidoAlexandra Plácido
Alexandra Plácido
Nuno ValeNuno Vale
Nuno Vale
Paula GameiroPaula Gameiro
Paula Gameiro
Aim: To test ocellatin peptides (ocellatins-PT2–PT6) for antibacterial and antibiofilm activities and synergy with antibiotics against Pseudomonas aeruginosa. Materials & methods: Normal- and checkerboard-broth microdilution methods were used. Biofilm studies included microtiter plate-based assays and microscopic analysis by confocal laser scanning microscopy and atomic force microscopy. Results: Ocellatins were more active against multidrug-resistant isolates of P. aeruginosa than against susceptible strains. Ocellatin-PT3 showed synergy with ciprofloxacin and ceftazidime against multidrug-resistant isolates and was capable of preventing the proliferation of 48-h mature biofilms at concentrations ranging from 4 to 8× the MIC. Treated biofilms had low viability and were slightly more disaggregated. Conclusion: Ocellatin-PT3 may be promising as a template for the development of novel antimicrobial peptides against P. aeruginosa.

28 September 2017 in APMIS
Verified
Journal Article
Closed access
PDF file
ADAnderson Dematei
Anderson Dematei
Rúben FernandesRúben Fernandes
Rúben Fernandes
Raquel SoaresRaquel Soares
Raquel Soares
HAHelena Alves
Helena Alves
JRJoachim Richter
Joachim Richter
Monica BotelhoMonica Botelho
Monica Botelho

10 November 2021 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
EBEder Barbosa
Eder Barbosa
Alexandra PlácidoAlexandra Plácido
Alexandra Plácido
DMDaniel C. Moreira
Daniel C. Moreira
LALucas Friaça Albuquerque
Lucas Friaça Albuquerque
ADAnderson Dematei
Anderson Dematei
Jose Roberto LeiteJose Roberto Leite
Jose Roberto Leite
In addition to the morphophysiological changes experienced by amphibians during metamorphosis, they must also deal with a different set of environmental constraints when they shift from the water to the land. We found that Pithecopus azureus secretes a single peptide ([M + H]+ = 658.38 Da) at the developmental stage that precedes the onset of terrestrial behaviour. De novo peptide and cDNA sequencing revealed that the peptide, named PaT-2, is expressed in tandem and is a member of the tryptophyllins family. In silico studies allowed us to identify the position of reactive sites and infer possible antioxidant mechanisms of the compounds. Cell-based assays confirmed the predicted antioxidant activity in mammalian microglia and neuroblast cells. The potential neuroprotective effect of PaT-2 was further corroborated in FRET-based live cell imaging assays, where the peptide prevented lipopolysaccharide-induced ROS production and glutamate release in human microglia. In summary, PaT-2 is the first peptide expressed during the ontogeny of P. azureus , right before the metamorphosing froglet leaves the aquatic environment to occupy terrestrial habitats. The antioxidant activity of PaT-2, predicted by in silico analyses and confirmed by cell-based assays, might be relevant for the protection of the skin of P. azureus adults against increased O 2 levels and UV exposure on land compared with aquatic environments.